Rheumatic Disease
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients with rheumatic diseases who undergo inpatient treatment 2) Patients must be able to agree the informed consent.
Exclusion criteria
Exclusion criteria: 1) Patients who refuse to participate this study 2) Patients for whom the physicians do not think suitable for this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To clarify predictors of the factors for development of glucocorticoid-induced Diabetes Mellitus in patients with Rheumatic Disease | — |
Secondary
| Measure | Time frame |
|---|---|
| Correlation between factors for development of glucocorticoid-induced Diabetes Mellitus in patients with Rheumatic Disease | — |
Countries
Japan
Contacts
Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Department of Nephrology, Rheumatology, Endocrinology and Metabolism